PRF1 and B-cell chronic lymphocytic leukemia: Indeed, addition of concanamycin, a specific perforin blocker [26], significantly suppressed the killing of autologous primary CLL cells by GIFT4-CLL primed T cells (Fig. 7a, b, d).